Corcept Therapeutics Inc header image

Corcept Therapeutics Inc

CORT

Equity

ISIN null / Valor 1812837

NASDAQ (2026-03-30)
USD 38.12+1.38%

Corcept Therapeutics Inc
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Corcept Therapeutics Inc is a pharmaceutical company that focuses on the discovery, development, and commercialization of drugs for the treatment of severe metabolic, oncologic, and psychiatric disorders. The company's board members, such as Daniel N. Swisher, Jr. and Gillian M. Cannon, bring extensive experience in the pharmaceutical industry, including leadership roles at prominent companies like Jazz Pharmaceuticals, Sunesis Pharmaceuticals, Merck and Co. Inc., UCB Inc., and Otsuka Pharmaceuticals. With a strong emphasis on research and development, Corcept Therapeutics Inc aims to provide innovative solutions to address unmet medical needs in various therapeutic areas.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-30.2%1Y
76.2%3Y
62.3%5Y

Performance

118%1Y
80.5%3Y
68.2%5Y

Volatility

Market cap

4055 M

Market cap (USD)

Daily traded volume (Shares)

1,956,434

Daily traded volume (Shares)

1 day high/low

51.95 / 50.17

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Galapagos NV
Galapagos NV Galapagos NV Valor: 2130343
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.16%EUR 25.40
Dynavox Group AB
Dynavox Group AB Dynavox Group AB Valor: 114900704
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.83%SEK 83.55
Amicus Therapeutics Inc
Amicus Therapeutics Inc Amicus Therapeutics Inc Valor: 2644388
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.14%USD 14.43
Emeis
Emeis Emeis Valor: 132546338
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.95%EUR 12.88
Agenus Inc
Agenus Inc Agenus Inc Valor: 134326284
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-4.42%USD 3.24
SOLVENTUM CORP
SOLVENTUM CORP SOLVENTUM CORP Valor: 133635906
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.10%USD 63.45
Straumann Holding Ltd
Straumann Holding Ltd Straumann Holding Ltd Valor: 117544866
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.15%CHF 81.28
Medacta Group Ltd
Medacta Group Ltd Medacta Group Ltd Valor: 46852522
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.40%CHF 148.20
COSMO Pharmaceuticals N.V.
COSMO Pharmaceuticals N.V. COSMO Pharmaceuticals N.V. Valor: 32590356
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.50%CHF 80.60
IVF HARTMANN Holding AG
IVF HARTMANN Holding AG IVF HARTMANN Holding AG Valor: 18762425
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%CHF 137.00